Showing 291-300 of 333 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Optimization of fast-acting venom insulins as therapeutic candidates for T1D | University of Utah | Helena Safavi | Improving Lives | 01-September-2022 to 31-August-2025 | $890,372.53 |
| Structural approaches to understand biased insulin signaling and design glucose-binding proteins for smart insulin therapeutics | University of Utah | Amber Vogel | Improving Lives | 01-March-2024 to 28-February-2027 | $228,995.00 |
| Promoting functional maturation of SC-derived beta-cells by novel Epigenetic regulators | University of Washington | Vincenzino Cirulli | Cures | 01-October-2024 to 30-September-2026 | $500,000.00 |
| microRNAs as regulators of stem cell differentiation into islet cells | University of Washington | Vincenzino Cirulli | Cures | 01-August-2025 to 31-July-2027 | $600,000.00 |
| A Multi-task Learning Framework for Developing Genetic Risk Score (GRS) Models of T1D for Multi-Ethnic Population | University of Washington | Shuai Huang | Cures | 01-August-2022 to 31-August-2025 | $300,081.37 |
| Effects of SGLT2 inhibition on early diabetic kidney disease: interrogation of renal energetics by functional imaging and single-cell transcriptomics | University of Washington | Petter Bjornstad | Improving Lives | 01-June-2024 to 30-November-2025 | $488,511.63 |
| METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D) | University of Washington | Petter Bjornstad | Improving Lives | 01-September-2025 to 31-August-2028 | $2,040,014.30 |
| Randomized trial of semaglutide for diabetic kidney disease in type 1 diabetes | University of Washington | Ian De Boer | Improving Lives | 01-September-2023 to 31-August-2026 | $2,107,411.00 |
| ICAM-1 Knock Out Pluripotent Stem Cells for Hypoimmune Type 1 Diabetes Therapy | University of Wisconsin-Madison (Board of Regents University of Wisconsin System) | Matthew Brown | Cures | 01-April-2025 to 31-March-2027 | $699,998.53 |
| Discovering early diagnostic markers of cardiovascular disease risk with lipidomics in a 30-year longitudinal prospective type 1 diabetes cohort | University of Wisconsin-Madison (Board of Regents University of Wisconsin System) | Judith Simcox | Improving Lives | 01-November-2022 to 31-October-2025 | $799,988.63 |